Home
EXAS
EXAS News

Latest Exact Sciences Corporation (EXAS) News on October 26, 2025

5 Growth Stocks to Strengthen Your Portfolio in Q4 After a Fabulous Q3

Zacks

16 days ago

5 Growth Stocks to Strengthen Your Portfolio in Q4 After a Fabulous Q3

How Recent Developments Are Reshaping the Story for Exact Sciences

Simply Wall St.

22 days ago

How Recent Developments Are Reshaping the Story for Exact Sciences

Here's Why Exact Sciences (EXAS) is a Strong Growth Stock

Zacks

24 days ago

Here's Why Exact Sciences (EXAS) is a Strong Growth Stock

Exact Sciences (EXAS) Just Flashed Golden Cross Signal: Do You Buy?

Zacks

25 days ago

Exact Sciences (EXAS) Just Flashed Golden Cross Signal: Do You Buy?

Why Exact Sciences (EXAS) is a Top Momentum Stock for the Long-Term

Zacks

a month ago

Why Exact Sciences (EXAS) is a Top Momentum Stock for the Long-Term

Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test

Business Wire

a month ago

Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test

Exact Sciences, Healthmine Partner to Boost Cologuard Screening Rates via Health Plan Incentives

Insider Monkey

a month ago

Exact Sciences, Healthmine Partner to Boost Cologuard Screening Rates via Health Plan Incentives

Healthmine and Exact Sciences Partner to Combine At-Home CRC Screening with Health Plan Incentives to Boost Preventive Care

Business Wire

a month ago

Healthmine and Exact Sciences Partner to Combine At-Home CRC Screening with Health Plan Incentives to Boost Preventive Care

Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term

Zacks

a month ago

Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term

Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs

Zacks

a month ago

Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs

Exact Sciences price target raised to $85 from $65 at Craig-Hallum

TipRanks

a month ago

Exact Sciences price target raised to $85 from $65 at Craig-Hallum

More Blood Tests for Cancer Hit the Market

Barrons.com

a month ago

More Blood Tests for Cancer Hit the Market

Exact Sciences And 2 Other Stocks Estimated To Be Trading Below Their Fair Value

Simply Wall St.

2 months ago

Exact Sciences And 2 Other Stocks Estimated To Be Trading Below Their Fair Value

Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run

Investor's Business Daily

2 months ago

Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run

Why Exact Sciences (EXAS) Stock Is Trading Up Today

StockStory

2 months ago

Why Exact Sciences (EXAS) Stock Is Trading Up Today

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

4 months ago

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

What's Fueling Tempus AI's Explosive Sales Growth?

Zacks

4 months ago

What's Fueling Tempus AI's Explosive Sales Growth?

Concerns Rise Over Exact Sciences Corp. (EXAS) Salesforce Reorganization Affecting Growth

Insider Monkey

4 months ago

Concerns Rise Over Exact Sciences Corp. (EXAS) Salesforce Reorganization Affecting Growth

Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care

Investor's Business Daily

4 months ago

Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care

The 5 Most Interesting Analyst Questions From Exact Sciences’s Q1 Earnings Call

StockStory

4 months ago

The 5 Most Interesting Analyst Questions From Exact Sciences’s Q1 Earnings Call

QGEN vs. EXAS: Which Stock Is the Better Value Option?

Zacks

4 months ago

QGEN vs. EXAS: Which Stock Is the Better Value Option?

Exact Sciences Expands Oncodetect Validation, Unveils MRD Innovation Roadmap.

Insider Monkey

4 months ago

Exact Sciences Expands Oncodetect Validation, Unveils MRD Innovation Roadmap.

Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks

StockStory

4 months ago

Q1 Rundown: Regeneron (NASDAQ:REGN) Vs Other Immuno-Oncology Stocks

Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?

Zacks

4 months ago

Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building?

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

Zacks

4 months ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

1 of Wall Street’s Favorite Stock with Promising Prospects and 2 to Turn Down

StockStory

4 months ago

1 of Wall Street’s Favorite Stock with Promising Prospects and 2 to Turn Down

High Growth Tech Stocks In The US To Watch This June 2025

Simply Wall St.

4 months ago

High Growth Tech Stocks In The US To Watch This June 2025

CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue?

Zacks

5 months ago

CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue?

Should You Continue to Hold EXAS Sciences Stock in Your Portfolio?

Zacks

5 months ago

Should You Continue to Hold EXAS Sciences Stock in Your Portfolio?

Freenome posts pivotal liquid biopsy data as FDA filing nears completion

MedTech Dive

5 months ago

Freenome posts pivotal liquid biopsy data as FDA filing nears completion

3 Mid-Cap Stocks in the Doghouse

StockStory

5 months ago

3 Mid-Cap Stocks in the Doghouse

Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap

Business Wire

5 months ago

Exact Sciences Announces Expanded Clinical Validation of the Oncodetect™ Test and Molecular Residual Disease Innovation Roadmap

Exact Sciences to Participate in June Investor Conference

Business Wire

5 months ago

Exact Sciences to Participate in June Investor Conference

3 Low-Volatility Stocks Walking a Fine Line

StockStory

5 months ago

3 Low-Volatility Stocks Walking a Fine Line

Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025

Business Wire

5 months ago

Exact Sciences Highlights Innovations in Early Cancer Detection and Precision Oncology at ASCO 2025

Exact Sciences Corporation (EXAS) Slid on Fear of Competition

Insider Monkey

5 months ago

Exact Sciences Corporation (EXAS) Slid on Fear of Competition

Morningstar Research

5 months ago

Analyst Report: Exact Sciences Corporation

EXAS Q1 Earnings Call: Outperformance Driven by Commercial Execution, New Products, and Margin Expansion

StockStory

5 months ago

EXAS Q1 Earnings Call: Outperformance Driven by Commercial Execution, New Products, and Margin Expansion

1 Healthcare Stock Worth Investigating and 2 to Ignore

StockStory

5 months ago

1 Healthcare Stock Worth Investigating and 2 to Ignore

2 Brilliant Stocks to Buy With $200 and Hold for 5 Years

Motley Fool

5 months ago

2 Brilliant Stocks to Buy With $200 and Hold for 5 Years

Exact Sciences Earns 2025 Great Place To Work® Certification™

Business Wire

5 months ago

Exact Sciences Earns 2025 Great Place To Work® Certification™

What To Expect From Natera’s (NTRA) Q1 Earnings

StockStory

6 months ago

What To Expect From Natera’s (NTRA) Q1 Earnings

Morningstar Research

6 months ago

Analyst Report: Exact Sciences Corporation

Analysts Have Made A Financial Statement On Exact Sciences Corporation's (NASDAQ:EXAS) First-Quarter Report

Simply Wall St.

6 months ago

Analysts Have Made A Financial Statement On Exact Sciences Corporation's (NASDAQ:EXAS) First-Quarter Report

Exact Sciences First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

6 months ago

Exact Sciences First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Exact Sciences Corp Earnings Call

Exact Sciences (EXAS) Stock Trades Up, Here Is Why

StockStory

6 months ago

Exact Sciences (EXAS) Stock Trades Up, Here Is Why

MT Newswires

6 months ago

RBC Raises Price Target on Exact Sciences to $54 From $52, Keeps Sector Perform Rating

EXAS Stock Up on Q1 Earnings & Revenue Beat, 2025 Sales View Raised

Zacks

6 months ago

EXAS Stock Up on Q1 Earnings & Revenue Beat, 2025 Sales View Raised

Exact Sciences to Participate in May Investor Conference

Business Wire

6 months ago

Exact Sciences to Participate in May Investor Conference

Exact Sciences Corp (EXAS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and New ...

GuruFocus.com

6 months ago

Exact Sciences Corp (EXAS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and New ...

Exact Sciences (NASDAQ:EXAS) Posts Better-Than-Expected Sales In Q1, Stock Soars

StockStory

6 months ago

Exact Sciences (NASDAQ:EXAS) Posts Better-Than-Expected Sales In Q1, Stock Soars

Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates

Zacks

6 months ago

Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates

Associated Press Finance

6 months ago

Exact Sciences: Q1 Earnings Snapshot

Exact Sciences Hikes Its Full-Year Outlook. But There's One First-Quarter Drawback.

Investor's Business Daily

6 months ago

Exact Sciences Hikes Its Full-Year Outlook. But There's One First-Quarter Drawback.

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

6 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Exact Sciences (EXAS) Reports Q1: Everything You Need To Know Ahead Of Earnings

StockStory

6 months ago

Exact Sciences (EXAS) Reports Q1: Everything You Need To Know Ahead Of Earnings

US High Growth Tech Stocks to Watch

Simply Wall St.

6 months ago

US High Growth Tech Stocks to Watch

Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025

Business Wire

6 months ago

Exact Sciences to Highlight Cologuard® Test Adherence and Predicted Preference Data at Digestive Disease Week (DDW) 2025

Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy?

Zacks

6 months ago

Certara, Inc. (CERT) Earnings Expected to Grow: Should You Buy?

This Exact Sciences Insider Increased Their Holding In The Last Year

Simply Wall St.

6 months ago

This Exact Sciences Insider Increased Their Holding In The Last Year

Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Zacks

6 months ago

Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Exact Sciences (EXAS): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential

Insider Monkey

6 months ago

Exact Sciences (EXAS): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential

2 Reasons to Like EXAS (and 1 Not So Much)

StockStory

6 months ago

2 Reasons to Like EXAS (and 1 Not So Much)

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Zacks

6 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test

Business Wire

6 months ago

Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

Investor's Business Daily

6 months ago

The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

StockStory

6 months ago

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

Tap Into the Silver Economy Boom With These Aging Demographics Stocks

Zacks

6 months ago

Tap Into the Silver Economy Boom With These Aging Demographics Stocks

JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups

Business Wire

6 months ago

JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

StockStory

6 months ago

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

2 Oversold Stocks Ready to Bounce Back and 1 to Approach with Caution

StockStory

6 months ago

2 Oversold Stocks Ready to Bounce Back and 1 to Approach with Caution

MT Newswires

7 months ago

Mizuho Initiates Exact Sciences at Outperform With $60 Price Target

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

StockStory

7 months ago

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

Exact Sciences Schedules First Quarter 2025 Earnings Call

Business Wire

7 months ago

Exact Sciences Schedules First Quarter 2025 Earnings Call

Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening

Business Wire

7 months ago

Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening

High Growth Tech Stocks To Watch In The US March 2025

Simply Wall St.

7 months ago

High Growth Tech Stocks To Watch In The US March 2025

Should You Retain Exact Sciences Stock in Your Portfolio Now?

Zacks

7 months ago

Should You Retain Exact Sciences Stock in Your Portfolio Now?

2 Small-Cap Stocks on Our Watchlist and 1 to Ignore

StockStory

7 months ago

2 Small-Cap Stocks on Our Watchlist and 1 to Ignore

Why Exact Sciences Corporation (EXAS) is Among the Best Diagnostics Stocks to Invest in Right Now

Insider Monkey

7 months ago

Why Exact Sciences Corporation (EXAS) is Among the Best Diagnostics Stocks to Invest in Right Now

Exact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound?

Zacks

7 months ago

Exact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound?

1 Healthcare Stock on Our Watchlist and 2 to Turn Down

StockStory

7 months ago

1 Healthcare Stock on Our Watchlist and 2 to Turn Down

Should You Invest in Exact Sciences Corp. (EXAS)?

Insider Monkey

7 months ago

Should You Invest in Exact Sciences Corp. (EXAS)?

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

StockStory

7 months ago

Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

PR Newswire

7 months ago

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

1 Stock Under $50 to Target This Week and 2 to Turn Down

StockStory

7 months ago

1 Stock Under $50 to Target This Week and 2 to Turn Down

MT Newswires

7 months ago

RBC Initiates Exact Sciences at Sector Perform With $52 Price Target

Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner

Business Wire

8 months ago

Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner

3 Top Cancer Biotechs to Keep An Eye On in 2025

Zacks

8 months ago

3 Top Cancer Biotechs to Keep An Eye On in 2025

Here’s What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS)

Insider Monkey

8 months ago

Here’s What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS)

Exact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy Now

Insider Monkey

8 months ago

Exact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy Now

Exploring Three High Growth Tech Stocks In The United States

Simply Wall St.

8 months ago

Exploring Three High Growth Tech Stocks In The United States

2 Stocks Down 59% and 34% to Buy and Hold

Motley Fool

8 months ago

2 Stocks Down 59% and 34% to Buy and Hold

Exact Sciences to Participate in March Investor Conferences

Business Wire

8 months ago

Exact Sciences to Participate in March Investor Conferences

Exact Sciences Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

8 months ago

Exact Sciences Full Year 2024 Earnings: EPS Misses Expectations

Morningstar Research

8 months ago

Analyst Report: Exact Sciences Corporation

Why Exact Sciences (EXAS) Shares Are Trading Lower Today

StockStory

8 months ago

Why Exact Sciences (EXAS) Shares Are Trading Lower Today

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Exact Sciences Corp Earnings Call

EXAS Q4 Loss Narrower Than Expected, Stock Falls, Revenues Up Y/Y

Zacks

8 months ago

EXAS Q4 Loss Narrower Than Expected, Stock Falls, Revenues Up Y/Y

Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

8 months ago

Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Share on Social Networks: